Recent News

• 09.16.2025 - SERB Pharmaceuticals Completes Acquisition of Y-mAbs Therapeutics
• 08.08.2025 - Y-mAbs Reports Second Quarter 2025 Financial Results and Recent Corporate Developments
• 08.08.2025 - Y-mAbs Reports Second Quarter 2025 Financial Results and Recent Corporate Developments
• 08.07.2025 - Y-mAbs to Announce Second Quarter 2025 Financial and Operating Results on August 8, 2025
• 08.07.2025 - Y-mAbs to Announce Second Quarter 2025 Financial and Operating Results on August 8, 2025
• 08.05.2025 - SERB Pharmaceuticals Agrees to Acquire Y-mAbs Therapeutics
• 08.05.2025 - SERB Pharmaceuticals Agrees to Acquire Y-mAbs Therapeutics

Recent Filings

• 09.02.2025 - SC 14D9/A Solicitation, recommendation statements
• 09.02.2025 - SC TO-T/A Tender offer statement by Third Party
• 08.20.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.18.2025 - SC 14D9 Solicitation, recommendation statements
• 08.18.2025 - SC TO-T Tender offer statement by Third Party
• 08.15.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.12.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.08.2025 - EX-99.1 EX-99.1
• 08.08.2025 - 8-K Current report